Profile data is unavailable for this security.
About the company
Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. Its portfolio also includes fiber optic sensor technology in the interventional cardiology market.
- Revenue in USD (TTM)1.31bn
- Net income in USD117.56m
- Incorporated1985
- Employees3.66k
- LocationHaemonetics Corp125 Summer StreetBOSTON 02110United StatesUSA
- Phone+1 (781) 848-7100
- Websitehttps://www.haemonetics.com
Mergers & acquisitions
Acquired company | HAE:NYQ since announced | Transaction value |
---|---|---|
Advanced Cooling Therapy Inc | 18.53% | 160.00m |
Opsens Inc | -2.33% | 245.87m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Envista Holdings Corp | 2.56bn | -120.40m | 3.09bn | 12.80k | -- | 0.7461 | 283.33 | 1.21 | -0.713 | -0.713 | 14.72 | 24.09 | 0.3904 | 3.89 | 6.29 | 200,226.60 | -1.83 | 1.94 | -2.15 | 2.34 | 56.35 | 57.65 | -4.70 | 5.29 | 1.93 | 5.09 | 0.2667 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
Tandem Diabetes Care Inc | 770.01m | -141.45m | 3.21bn | 2.40k | -- | 13.20 | -- | 4.17 | -2.17 | -2.17 | 11.82 | 3.76 | 0.8126 | 2.74 | 8.35 | 320,837.10 | -14.93 | -10.08 | -18.48 | -12.23 | 49.28 | 51.77 | -18.37 | -11.59 | 3.01 | -- | 0.5884 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
LivaNova PLC | 1.19bn | -31.77m | 3.22bn | 2.90k | -- | 2.63 | 191.07 | 2.71 | -0.5911 | -0.5911 | 21.89 | 22.56 | 0.4985 | 2.57 | 6.11 | 408,634.10 | -1.33 | -6.01 | -1.54 | -7.42 | 67.89 | 66.99 | -2.67 | -13.56 | 2.71 | 2.52 | 0.3383 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
Procept Biorobotics Corp | 156.33m | -103.37m | 3.43bn | 626.00 | -- | 12.99 | -- | 21.95 | -2.12 | -2.12 | 3.20 | 5.14 | 0.4685 | 1.81 | 4.08 | 249,722.00 | -30.98 | -- | -34.68 | -- | 53.47 | -- | -66.12 | -- | 7.44 | -- | 0.1629 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
Axonics Inc | 387.14m | -15.95m | 3.44bn | 797.00 | -- | 5.48 | -- | 8.87 | -0.3134 | -0.3134 | 7.76 | 12.29 | 0.5606 | 1.20 | 8.53 | 485,744.00 | -2.31 | -12.67 | -2.52 | -13.76 | 75.25 | 70.04 | -4.12 | -29.68 | 8.04 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
Integer Holdings Corp | 1.63bn | 98.09m | 4.08bn | 10.50k | 42.30 | 2.68 | 20.51 | 2.50 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.91 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.54 | 26.94 | 6.01 | 6.40 | 2.01 | 3.74 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
Haemonetics Corporation | 1.31bn | 117.56m | 4.50bn | 3.66k | 38.75 | 4.69 | 20.96 | 3.44 | 2.29 | 2.29 | 25.47 | 18.90 | 0.6339 | 2.10 | 6.79 | 357,958.70 | 5.69 | 5.02 | 6.57 | 6.07 | 53.69 | 51.74 | 8.98 | 8.11 | 1.50 | 18.09 | 0.457 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
TransMedics Group Inc | 296.92m | -10.20m | 4.53bn | 584.00 | -- | 28.33 | 4,136.86 | 15.26 | -0.335 | -0.335 | 8.96 | 4.85 | 0.5874 | 3.08 | 4.93 | 508,422.90 | -2.02 | -16.08 | -2.19 | -17.95 | 62.40 | 65.37 | -3.43 | -40.47 | 8.76 | -- | 0.7607 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Inspire Medical Systems Inc | 660.91m | -15.73m | 4.60bn | 1.01k | -- | 7.80 | -- | 6.96 | -0.5374 | -0.5374 | 22.46 | 19.85 | 1.05 | 3.14 | 10.01 | 653,721.10 | -2.50 | -11.27 | -2.80 | -12.60 | 84.65 | 84.47 | -2.38 | -13.57 | 7.25 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
Merit Medical Systems Inc | 1.28bn | 101.95m | 4.70bn | 6.95k | 46.38 | 3.79 | 24.11 | 3.66 | 1.74 | 1.74 | 21.96 | 21.35 | 0.64 | 2.32 | 7.32 | 184,648.80 | 5.08 | 2.45 | 5.65 | 2.77 | 46.54 | 44.50 | 7.94 | 3.91 | 4.38 | 11.61 | 0.3922 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
Glaukos Corp | 326.43m | -140.87m | 5.41bn | 907.00 | -- | 11.88 | -- | 16.58 | -2.88 | -2.88 | 6.68 | 9.04 | 0.3426 | 1.72 | 7.74 | 359,905.20 | -14.78 | -8.73 | -15.91 | -9.35 | 76.18 | 74.77 | -43.16 | -28.69 | 4.68 | -38.38 | 0.4395 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
Lantheus Holdings Inc | 1.37bn | 460.53m | 5.48bn | 834.00 | 12.06 | 5.79 | 10.50 | 4.01 | 6.55 | 6.55 | 19.42 | 13.64 | 0.8587 | 8.78 | 4.71 | 1,637,434.00 | 28.96 | 6.69 | 34.54 | 7.73 | 64.02 | 53.90 | 33.72 | 9.02 | 4.55 | -- | 0.3733 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
DENTSPLY SIRONA Inc | 3.94bn | -95.00m | 5.71bn | 15.00k | -- | 1.75 | 22.58 | 1.45 | -0.4468 | -0.4468 | 18.69 | 15.69 | 0.5326 | 2.94 | 6.02 | 262,666.70 | -1.24 | -1.14 | -1.52 | -1.32 | 52.61 | 53.65 | -2.34 | -2.51 | 0.9692 | 3.29 | 0.3908 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
Novanta Inc | 893.45m | 69.29m | 5.83bn | 2.90k | 84.49 | 8.55 | 49.77 | 6.52 | 1.92 | 1.92 | 24.77 | 18.99 | 0.6778 | 2.99 | 6.11 | 308,086.90 | 5.26 | 5.46 | 5.92 | 6.34 | 45.07 | 43.24 | 7.76 | 7.71 | 1.77 | 4.42 | 0.4319 | 0.00 | 2.41 | 7.49 | -1.58 | 8.21 | 4.19 | -- |
Stevanato Group SpA | 1.17bn | 147.24m | 6.08bn | 5.64k | 36.29 | -- | 31.69 | 5.19 | 0.5553 | 0.5553 | 4.41 | -- | -- | -- | -- | 207,886.90 | -- | -- | -- | -- | 30.81 | -- | 12.57 | -- | -- | 32.91 | -- | -- | 10.34 | -- | 1.95 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 6.67m | 13.14% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 5.42m | 10.68% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 5.25m | 10.34% |
Wellington Management Co. LLPas of 31 Mar 2024 | 4.27m | 8.41% |
Neuberger Berman Investment Advisers LLCas of 31 Mar 2024 | 3.79m | 7.46% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.83m | 3.61% |
Franklin Advisers, Inc.as of 31 Mar 2024 | 1.29m | 2.54% |
Royce & Associates LPas of 31 Mar 2024 | 1.27m | 2.49% |
T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 1.22m | 2.40% |
Geode Capital Management LLCas of 31 Mar 2024 | 1.13m | 2.22% |